Terminated OBSERVATIONAL NCT03899506

Olanzapine Versus Midazolam for Agitation (OvM)

Prospective Observational Investigation of Olanzapine Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department

Sponsor: Hennepin Healthcare Research Institute

Conditions Agitation,Psychomotor

Interventions Midazolam Olanzapine

Updated 6 times since 2019 Last updated: May 9, 2019 Started: Jun 18, 2018 Primary completion: Jul 16, 2018 Completion: Jul 16, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Investigator Voluntary Pause

Other terminated trials from Hennepin Healthcare Research Institute

See all terminations from Hennepin Healthcare Research Institute

Other Agitation,Psychomotor trials with similar outcome

Browse all Agitation,Psychomotor trials

A observational or N/A phase clinical study on Agitation,Psychomotor, this trial is terminated or withdrawn. The trial is conducted by Hennepin Healthcare Research Institute and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Apr 2020 — Jan 2021 [monthly]

Terminated
Jun 2019 — Apr 2020 [monthly]

Terminated

Status: Recruiting → Terminated

▶ Show 1 earlier version

May 2019 — Jun 2019 [monthly]

Recruiting

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hennepin Healthcare Research Institute

Data source: Hennepin Healthcare Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States